The present invention pertains generally to systems and methods for cryoablating internal tissue. More particularly, the present invention pertains to devices and methods for controlling the tip temperature of a cryoablation catheter during a cryoablation procedure. The present invention is particularly, but not exclusively, useful for obtaining a pre-selected cryoablation catheter tip temperature by controlling the “back pressure” in a return line leading from a refrigerant expansion chamber.
As the word itself implies, “cryoablation” involves the ablation of tissue (i.e. tissue necrosis or destruction) using extremely low (i.e. cryogenic) temperatures. Typically, cryoablation requires lowering the temperature of the tissue to below approximately minus twenty degrees Centigrade (−20° C.). However, more efficient ablation procedures often call for temperatures as low as minus eighty eight degrees Centigrade (−88° C.) or lower.
In some cases, cell survivability depends not only on the cryoablation temperature, but also the rate at which the cells are cooled to the cryoablation temperature and the rate at which the cooled cells are subsequently warmed. Thus, it is often desirable to control both the cooling and warming rates in a cryoablation procedure. This control, in turn, requires that the temperature of an operative contact surface in the cryoablation device be controlled over a selected temperature range. Another instance in which it is desirable to control the temperature of a cryoablation tip or contact surface occurs when it is necessary to cryoablate tissue to a specific thickness (i.e. at a pre-selected depth from the contact surface). In such a case, it is important to control both the tip temperature and contact time to control the ablation depth.
It is often desirable to cryoablate internal tissue in a relatively non-invasive procedure. For this purpose, cryocatheters have been developed, such as the cryocatheter and associated refrigeration system that is disclosed in co-pending U.S. patent application Ser. No. 10/243,997, entitled “A Refrigeration Source for a Cryoablation Catheter.” Co-pending U.S. application Ser. No. 10/243,997 was filed on Sep. 12, 2002, is assigned to the same assignee as the present invention, and is hereby incorporated by reference herein. In one exemplary application of a cryocatheter, conduction blocks can be created in the tissue that are particularly effective for curing heart arrhythmias, such as atrial fibrillation.
In a typical cryocatheter procedure, the distal portion (i.e. cryotip) of the catheter is positioned near or in contact with the tissue requiring ablation (i.e. the target tissue). Next, the cryotip is cooled to a cryogenic temperature to thereby cool and ablate the target tissue. Typically, this is accomplished by expanding a fluid refrigerant into an expansion chamber near the catheter tip and exhausting the expanded refrigerant from the chamber through a return line. For this expansion, the pressure of the refrigerant as it enters the chamber, as well as the pressure in the return line (back pressure), will affect the temperature of the cryotip and the instantaneous cooling power of the cryocatheter. In addition, for a cryoablation system in which the refrigerant undergoes a phase change during expansion (i.e. transitions from a liquid to a gaseous state), the back pressure effects the actual refrigerant boiling temperature. This boiling temperature, in turn, controls the temperature of the cryoablation catheter tip.
In light of the above, it is an object of the present invention to provide systems and methods for controlling the tip temperature of a cryoablation catheter. It is another object of the present invention to provide a temperature control system for a cryoablation device that can either stabilize the cryoablation tip at a constant tip temperature or vary the temperature of the cryoablation tip in accordance with a predetermined schedule. Yet another object of the present invention is to provide a temperature control system for a cryoablation device which is easy to use, relatively simple to implement, and comparatively cost effective.
The present invention is directed to a cryoablation device having a temperature control system. For the present invention, the device includes an elongated catheter tube that has a central lumen and is formed with a closed distal tip. The device further includes a refrigerant supply unit that is connected to the proximal end of a supply line. The other end of the supply line (i.e. the distal end) is positioned in the central lumen of the catheter tube and distanced from the distal tip. With this cooperation of structure, an expansion chamber is established in the central lumen between the distal end of the supply tube and the closed distal tip of the catheter tube.
In a typical embodiment, the supply line includes a supply tube and a capillary tube, with the capillary tube attached to the distal end of the supply tube. With this combination, the refrigerant supply unit can be activated to introduce a regulated flow of refrigerant into the supply tube for subsequent flow through the capillary tube. From the capillary tube, the refrigerant expands into the expansion chamber absorbing heat as it expands. For the present invention, the device also includes a return line to exhaust expanded refrigerant from the expansion chamber. In a typical embodiment, the return line is established between the supply line and catheter tube. For example, the return line can be established between the inner surface of the catheter tube and the outer surface of the supply line (e.g. the outer surfaces of the supply tube and capillary tube).
For the present invention, the temperature control system of the cryoablation device includes a valve that is positioned at a predetermined location along the return line. Typically, the valve is positioned along the return line to remain at an extracorporeal location throughout a cryoablation procedure. For the temperature control system, the valve is adjustable to vary a pressure within the return line to control the operational temperature at the distal tip of the catheter tube. Specifically, as detailed further below, the valve can be used to vary the pressure in the return line to thereby increase or decrease the tip temperature.
In one aspect of the present invention, the temperature control system includes a control unit and a sensor for measuring a temperature at the distal tip of the catheter tube. For the system, the control unit is configured to compare the measured temperature at the distal tip with a pre-selected temperature and create an error signal. The control unit is connected to the valve, allowing the control unit to adjust the valve until the error signal is a nullity. The result is that the pre-selected temperature is obtained at the distal tip of the catheter tube. With this cooperation of structure, the control unit can be programmed to maintain a pre-selected temperature or vary the tip temperature in accordance with a predetermined schedule.
In a particular embodiment of the device, a fluid refrigerant is used that transitions from a liquid state to a gaseous state as it expands into the expansion chamber. Heat absorbed by the refrigerant during this phase transition (i.e. latent heat) cools the distal tip of the catheter tube and an operative surface that is placed in contact with tissue to be cryoablated. More specifically, for the phase change refrigerant, the boiling point (Tboiling) of the refrigerant will be a function of the pressure in the expansion chamber where the refrigerant boils. As a consequence, the valve can be used to vary the pressure in the expansion chamber, which in turn, varies the temperature at which the refrigerant boils. For a typical refrigerant, such as nitrous oxide, this effect is more pronounced at lower pressures. Stated another way, at low pressures, a relatively small change in pressure results in a relatively large change in boiling temperature. Thus, in one aspect of the present invention, the device is operated at relatively low expansion chamber pressures (e.g. pressures less than 10 atmospheres) to allow the tip temperature to be controlled using relatively small pressure variations.
The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
Referring initially to
Referring now to
As shown in
Referring back to
With the combination of structure described above and shown in
In one embodiment of the cryoablation device 10, a fluid refrigerant is used that transitions from a liquid state to a gaseous state as it expands into the expansion chamber 26. A suitable refrigerant supply unit 20 for delivering a refrigerant in a liquid state to the distal end 32 of a capillary tube 30 for transition to a gaseous state in the expansion chamber 26 is disclosed in co-pending U.S. patent application Ser. No. 10/243,997, entitled “A Refrigeration Source for a Cryoablation Catheter” filed on Sep. 12, 2002, which is assigned to the same assignee as the present invention. Co-pending U.S. application Ser. No. 10/243,997 is incorporated by reference herein. Heat absorbed by the refrigerant during this phase transition (i.e. latent heat) cools the tip member 22 of the catheter 14.
Referring now to
Referring back to
Cross-referencing
While the particular System And Method For Varying Return Pressure To Control Tip Temperature Of A Cryoablation Catheter as herein shown and disclosed in detail are fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that they are merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of construction or design herein shown other than as described in the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
3605725 | Bentov | Sep 1971 | A |
3613689 | Crump et al. | Oct 1971 | A |
3696813 | Wallach | Oct 1972 | A |
3913581 | Ritson et al. | Oct 1975 | A |
4018227 | Wallach | Apr 1977 | A |
4456017 | Miles | Jun 1984 | A |
4586923 | Gould et al. | May 1986 | A |
4813434 | Buchbinder et al. | Mar 1989 | A |
4815478 | Buchbinder et al. | Mar 1989 | A |
4886067 | Palermo | Dec 1989 | A |
4960134 | Webster, Jr. | Oct 1990 | A |
4960411 | Buchbinder | Oct 1990 | A |
4976688 | Rosenblum | Dec 1990 | A |
5037391 | Hammerslag et al. | Aug 1991 | A |
5042985 | Elliott et al. | Aug 1991 | A |
5108368 | Hammerslag et al. | Apr 1992 | A |
5114414 | Buchbinder | May 1992 | A |
5125895 | Buchbinder et al. | Jun 1992 | A |
5139496 | Hed | Aug 1992 | A |
5190050 | Nitzsche | Mar 1993 | A |
5242441 | Avitall | Sep 1993 | A |
5281213 | Milder et al. | Jan 1994 | A |
5281215 | Milder | Jan 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5322064 | Lundquist | Jun 1994 | A |
5330466 | Imran | Jul 1994 | A |
5334145 | Lundquist et al. | Aug 1994 | A |
5368564 | Savage | Nov 1994 | A |
5423807 | Milder | Jun 1995 | A |
5507725 | Savage et al. | Apr 1996 | A |
5656030 | Hunjan et al. | Aug 1997 | A |
5715817 | Stevens-Wright et al. | Feb 1998 | A |
5759182 | Varney et al. | Jun 1998 | A |
5876399 | Chja et al. | Mar 1999 | A |
5899898 | Arless et al. | May 1999 | A |
5899899 | Arless et al. | May 1999 | A |
5906590 | Hunjan et al. | May 1999 | A |
5928191 | Houser et al. | Jul 1999 | A |
5944689 | Houser et al. | Aug 1999 | A |
5992158 | Goddard et al. | Nov 1999 | A |
6013052 | Durman et al. | Jan 2000 | A |
6024740 | Lesh et al. | Feb 2000 | A |
6048919 | McCullough | Apr 2000 | A |
6066125 | Webster, Jr. | May 2000 | A |
6106518 | Wittenberger et al. | Aug 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6123699 | Webster, Jr. | Sep 2000 | A |
6139544 | Mikus et al. | Oct 2000 | A |
6171277 | Ponzi | Jan 2001 | B1 |
6183435 | Bumbalough et al. | Feb 2001 | B1 |
6183463 | Webster, Jr. | Feb 2001 | B1 |
6198974 | Webster, Jr. | Mar 2001 | B1 |
6210407 | Webster | Apr 2001 | B1 |
6235019 | Lehmann et al. | May 2001 | B1 |
6251105 | Mikus et al. | Jun 2001 | B1 |
6254568 | Ponzi | Jul 2001 | B1 |
6267746 | Bumbalough | Jul 2001 | B1 |
6280439 | Martin et al. | Aug 2001 | B1 |
6283959 | Lalonde et al. | Sep 2001 | B1 |
6319248 | Nohon | Nov 2001 | B1 |
6332880 | Yang et al. | Dec 2001 | B1 |
6346099 | Altman | Feb 2002 | B1 |
6383180 | Lalonde et al. | May 2002 | B1 |
6407149 | McCullough | Jun 2002 | B1 |
6413234 | Thompson et al. | Jul 2002 | B1 |
6440126 | Abboud et al. | Aug 2002 | B1 |
6468260 | Bumbalough et al. | Oct 2002 | B1 |
6468268 | Abboud et al. | Oct 2002 | B1 |
6471693 | Carroll et al. | Oct 2002 | B1 |
6485455 | Thompson et al. | Nov 2002 | B1 |
6500167 | Webster, Jr. | Dec 2002 | B1 |
6522933 | Nguyen | Feb 2003 | B2 |
6527769 | Langberg et al. | Mar 2003 | B2 |
6540725 | Ponzi | Apr 2003 | B1 |
6540740 | Lehmann et al. | Apr 2003 | B2 |
6547785 | Heiner et al. | Apr 2003 | B1 |
6551271 | Nguyen | Apr 2003 | B2 |
6562030 | Abboud et al. | May 2003 | B1 |
6569114 | Ponzi et al. | May 2003 | B2 |
6569158 | Abboud et al. | May 2003 | B1 |
6571131 | Nguyen | May 2003 | B1 |
6575966 | Lane et al. | Jun 2003 | B2 |
6579278 | Bencini | Jun 2003 | B1 |
6579287 | Wittenberger et al. | Jun 2003 | B2 |
6585717 | Wittenberger et al. | Jul 2003 | B1 |
6585718 | Hayzelden et al. | Jul 2003 | B2 |
6585728 | Heiner et al. | Jul 2003 | B2 |
6585729 | Eum | Jul 2003 | B1 |
6589234 | Lalonde et al. | Jul 2003 | B2 |
6592577 | Abboud et al. | Jul 2003 | B2 |
6602278 | Thompson et al. | Aug 2003 | B1 |
6605086 | Hayzelden et al. | Aug 2003 | B2 |
6605087 | Swartz et al. | Aug 2003 | B2 |
6607505 | Thompson et al. | Aug 2003 | B1 |
6610058 | Flores | Aug 2003 | B2 |
6635053 | Lalonde et al. | Oct 2003 | B1 |
6733494 | Abboud et al. | May 2004 | B2 |
6755823 | Lalonde | Jun 2004 | B2 |
6761714 | Abboud et al. | Jul 2004 | B2 |
6991630 | Ryba | Jan 2006 | B2 |
20010021847 | Abboud et al. | Sep 2001 | A1 |
20010025075 | Smith et al. | Sep 2001 | A1 |
20020025998 | McCullough et al. | Feb 2002 | A1 |
20020062122 | Lehmann et al. | May 2002 | A1 |
20020111612 | Lalonde et al. | Aug 2002 | A1 |
20020115989 | Abboud et al. | Aug 2002 | A1 |
20030004504 | Abboud et al. | Jan 2003 | A1 |
20030009160 | Carroll et al. | Jan 2003 | A1 |
20030018326 | Abboud et al. | Jan 2003 | A1 |
20030097124 | Lehmann et al. | May 2003 | A1 |
20040049178 | Abboud et al. | Mar 2004 | A1 |
20040054361 | Lehmann et al. | Mar 2004 | A1 |
Number | Date | Country | |
---|---|---|---|
20060004350 A1 | Jan 2006 | US |